Evidence map›Paper›PMID 33229462›Full record

ArticleScience translational medicine2020

Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2.

Alexandra Popa, Jakob-Wendelin Genger, Michael D Nicholson, Thomas Penz, Daniela Schmid, Stephan W Aberle, Benedikt Agerer, Alexander Lercher, Lukas Endler, Henrique Colaço and 28 more

Open access · hybridAbstract read
In one paragraph

Article in Science translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 162 papers.

0numbers the graph read from it
0cells of the map it votes in
162citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

162 citing papers in PubMed, 258 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Early unrecognised SARS-CoV-2 introductions shaped the first pandemic wave, Sweden, 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  18. Article
  19. Article
  20. CD4Science advances · 2024
    Article

102 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 11 institutions in 3 countries.

Alexandra PopaCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0001-7156-272X
Jakob-Wendelin GengerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0003-4502-1094
Michael D NicholsonDepartment of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0003-2813-8979
Thomas PenzCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
Daniela SchmidAustrian Agency for Health and Food Safety (AGES), 1220 Vienna, Austria.
Stephan W AberleCenter for Virology, Medical University of Vienna, 1090 Vienna, Austria.
Benedikt AgererCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0002-0044-8396
Alexander LercherCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0003-3478-5304
Lukas EndlerBioinformatics and Biostatistics Platform, Department of Biomedical Sciences, University of Veterinary Medicine, 1210 Vienna, Austria.ORCID 0000-0002-9115-8756
Henrique ColaçoCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0002-2026-0163
Mark SmythCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0003-2592-1722
Michael SchusterCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0003-2975-8969
Miguel L GrauInstitute for Research in Biomedicine (IRB), 08028 Barcelona, Spain.ORCID 0000-0002-5137-9976
Francisco Martínez-JiménezInstitute for Research in Biomedicine (IRB), 08028 Barcelona, Spain.ORCID 0000-0001-7804-1134
Oriol PichInstitute for Research in Biomedicine (IRB), 08028 Barcelona, Spain.ORCID 0000-0002-1956-1882
Wegene BorenaInstitute of Virology, Medical University Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-8011-5825
Erich PawelkaDepartment of Medicine IV, Kaiser Franz Josef Hospital, 1100 Vienna, Austria.
Zsofia KeszeiCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0001-7571-0566
Martin SenekowitschCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0002-4089-4104
Jan LaineCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0001-8906-9562
Judith H AberleCenter for Virology, Medical University of Vienna, 1090 Vienna, Austria.
Monika Redlberger-FritzCenter for Virology, Medical University of Vienna, 1090 Vienna, Austria.
Mario KarolyiDepartment of Medicine IV, Kaiser Franz Josef Hospital, 1100 Vienna, Austria.ORCID 0000-0002-9870-2339
Alexander ZoufalyDepartment of Medicine IV, Kaiser Franz Josef Hospital, 1100 Vienna, Austria.
Sabine MaritschnikAustrian Agency for Health and Food Safety (AGES), 1220 Vienna, Austria.
Martin BorkovecAustrian Agency for Health and Food Safety (AGES), 1220 Vienna, Austria.
Peter HufnaglAustrian Agency for Health and Food Safety (AGES), 1220 Vienna, Austria.ORCID 0000-0002-6299-3226
Manfred NairzDepartment of Internal Medicine II, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-9103-7041
Günter WeissDepartment of Internal Medicine II, Medical University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0003-0709-2158
Michael T WolfingerDepartment of Theoretical Chemistry, University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-0925-5205
Dorothee von LaerInstitute of Virology, Medical University Innsbruck, 6020 Innsbruck, Austria.
Giulio Superti-FurgaCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
Nuria Lopez-BigasInstitute for Research in Biomedicine (IRB), 08028 Barcelona, Spain.
Elisabeth Puchhammer-StöcklCenter for Virology, Medical University of Vienna, 1090 Vienna, Austria.
Franz AllerbergerAustrian Agency for Health and Food Safety (AGES), 1220 Vienna, Austria.
Franziska MichorDepartment of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0003-4869-8842
Christoph BockCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.ORCID 0000-0001-6091-3088
Andreas BergthalerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria. abergthaler@cemm.oeaw.ac.at.ORCID 0000-0003-0597-1976
Austrian Academy of Sciences · ATAustrian Agency for Health and Food Safety · ATInnsbruck Medical University · ATMedical University of Vienna · ATInstitute for Research in Biomedicine · ESKaiser-Franz-Josef-Spital · ATBroad Institute · USHarvard University · USInstitució Catalana de Recerca i Estudis Avançats · ESUniversity of Veterinary Medicine Vienna · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Superspreading events shaped the coronavirus disease 2019 (COVID-19) pandemic, and their rapid identification and containment are essential for disease control. Here, we provide a national-scale analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) superspreading during the first wave of infections in Austria, a country that played a major role in initial virus transmissions in Europe. Capitalizing on Austria's well-developed epidemiological surveillance system, we identified major SARS-CoV-2 clusters during the first wave of infections and performed deep whole-genome sequencing of more than 500 virus samples. Phylogenetic-epidemiological analysis enabled the reconstruction of superspreading events and charts a map of tourism-related viral spread originating from Austria in spring 2020. Moreover, we exploited epidemiologically well-defined clusters to quantify SARS-CoV-2 mutational dynamics, including the observation of low-frequency mutations that progressed to fixation within the infection chain. Time-resolved virus sequencing unveiled viral mutation dynamics within individuals with COVID-19, and epidemiologically validated infector-infectee pairs enabled us to determine an average transmission bottleneck size of 10

Indexed as

AustriaBase SequenceCOVID-19Host-Pathogen InteractionsHumansMutationMutation RatePhylogenySARS-CoV-2

Identifiers

PMID33229462
PMCPMC7857414
OpenAlexW3108686166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.